Process: The committee scheduled twice monthly conference calls from January, 2013 through September, 2014 and developed initial pathways. The physicians presented draft pathways based upon expertise and clinical interest which were then modified according to committee and evidence review. Network experts were consulted as requested by the committee. Once the draft pathways were completed they were circulated to the 22 SCBCN program transplant physicians for comment. Comments were collated and sent to the committee for review for final revisions.
Outcome: Twelve standardized BMT pathways resulted from this process covering acute and chronic leukemias, lymphomas, myelodysplastic syndromes, multiple myeloma, myeloproliferative syndromes, graft-versus-host disease prophylaxis, and stem cell mobilization. Consensus on the treatment pathways was readily achieved setting the stage for further clinical and research collaboration. Final versions of the pathways were published on the Sarah Cannon SharePoint site for program access. SCBCN members agreed to implement the pathways to guide BMT care. Physicians may choose to treat a patient off-pathway but must submit a variance form for tracking. Variances are reviewed at the SCBCN quarterly Network Quality Committee Meeting.
Implementation of the pathways will require standardized order sets be created and PharmDs from Network programs are creating standardized order sets for each pathway. Pathways will be built into the electronic BMT Patient Management Software and variances tracked electronically.